Conversely, the reduction of CD146 in CRC cells facilitates the transcriptional activation of β-catenin/TCF/LEF complex and thus endows CRC cells with stem cell phenotype, as well as enhanced self-renewal, tumor initiating capacity and chemoresistance. The gene discussed is MCAM; the disease is neoplasm.